High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth

Prostate

Volumn 72, Issue 15, 2012, Pages 1678-1687

  Ruiz, Christian ^a   Oeggerli, Martin ^a   Germann, Markus ^b   Gluderer, Silvia ^c   Stocker, Hugo ^c   Andreozzi, Mariacarla ^a   Thalmann, George N ^b   Cecchini, Marco G ^b   Zellweger, Tobias ^d   Stürm, Susanna ^a   Koivisto, Pasi A ^e   Helin, Heikki J ^f   Gelmann, Edward P ^g   Glass, Andrew G ^h   Gasser, Thomas C ⁱ   Terracciano, Luigi M ^a   Bachmann, Alexander ⁱ   Wyler, Stephen ⁱ   Bubendorf, Lukas ^a   Rentsch, Cyrill A ^a,i  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c ETH ZURICH   (Switzerland)

^d Division of Urology   (Switzerland)

^e SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h CENTER FOR HEALTH RESEARCH   (United States)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

castration resistance; Gleason; Ki67; Madm; NRBP1; proliferation; prostate cancer; survival; TSC 22

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS RECEPTOR; KI 67 ANTIGEN; NUCLEAR RECEPTOR BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RNA INTERFERENCE; TISSUE MICROARRAY; UPREGULATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FINLAND; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SURVIVAL RATE; SWITZERLAND; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EID: 84867075650     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22521     Document Type: Article

References (24)

1. Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK,. (eds). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD Based on November 2010 SEER data submission, posted to the SEER web site 2011.
2. Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P, Mihatsch MJ,. Ki67 labelling index: An independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol 1996; 178 (4): 437-441.
3. Bubendorf L, Tapia C, Gasser TC, Casella R, Grunder B, Moch H, Mihatsch MJ, Sauter G,. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. Hum Pathol 1998; 29 (9): 949-954.
4. Zellweger T, Gunther S, Zlobec I, Savic S, Sauter G, Moch H, Mattarelli G, Eichenberger T, Curschellas E, Rufenacht H, Bachmann A, Gasser TC, Mihatsch MJ, Bubendorf L,. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer 2009; 124 (9): 2116-2123.
5. Rubio J, Ramos D, Lopez-Guerrero JA, Iborra I, Collado A, Solsona E, Almenar S, Llombart-Bosch A,. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens. Eur Urol 2005; 48 (5): 745-751.
6. Bonkhoff H, Berges R,. From pathogenesis to prevention of castration resistant prostate cancer. Prostate 2010; 70 (1): 100-112.
7. Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L,. Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer 2005; 113 (4): 619-628.
8. Hanahan D, Weinberg RA,. Hallmarks of cancer: The next generation. Cell 2011; 144 (5): 646-674.
9. Gluderer S, Oldham S, Rintelen F, Sulzer A, Schutt C, Wu X, Raftery LA, Hafen E, Stocker H,. Bunched, the Drosophila homolog of the mammalian tumor suppressor TSC-22, promotes cellular growth. BMC Dev Biol 2008; 8: 10.
10. Rentsch CA, Cecchini MG, Schwaninger R, Germann M, Markwalder R, Heller M, van der Pluijm G, Thalmann GN, Wetterland A,. Differential expression of TGFbeta-stimulated clone 22 in normal prostate and prostate cancer. Int J Cancer 2006; 118 (4): 899-906.
11. Sprenger CC, Haugk K, Sun S, Coleman I, Nelson PS, Vessella RL, Ludwig DL, Wu JD, Plymate SR,. Transforming growth factor-{beta}-stimulated clone-22 is an androgen-regulated gene that enhances apoptosis in prostate cancer following insulin-like growth factor-i receptor inhibition. Clin Cancer Res 2009; 15 (24): 7634-7641.
12. Homig-Holzel C, van Doorn R, Vogel C, Germann M, Cecchini MG, Verdegaal E, Peeper DS,. Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence. EMBO J 2011; 30 (9): 1753-1765.
13. Gluderer S, Brunner E, Germann M, Jovaisaite V, Li C, Rentsch CA, Hafen E, Stocker H,. Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila. J Biol 2010; 9 (1): 9.
14. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D,. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007; 3: 89.
15. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M,. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437 (7062): 1173-1178.
16. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP,. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4 (7): 844-847.
17. Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L,. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 2003; 55 (1): 20-29.
18. Ruiz C, Holz DR, Oeggerli M, Schneider S, Gonzales IM, Kiefer JM, Zellweger T, Bachmann A, Koivisto PA, Helin HJ, Mousses S, Barrett MT, Azorsa DO, Bubendorf L,. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer. J Pathol 2011; 223 (4): 543-552.
19. Hooper JD, Baker E, Ogbourne SM, Sutherland GR, Antalis TM,. Cloning of the cDNA and localization of the gene encoding human NRBP, a ubiquitously expressed, multidomain putative adapter protein. Genomics 2000; 66 (1): 113-118.
20. Lim R, Winteringham LN, Williams JH, McCulloch RK, Ingley E, Tiao JY, Lalonde JP, Tsai S, Tilbrook PA, Sun Y, Wu X, Morris SW, Klinken SP,. MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1. J Biol Chem 2002; 277 (43): 40997-41008.
21. Wang H, Sun X, Luo Y, Lin Z, Wu J,. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity. FEBS Lett 2006; 580 (25): 6015-6021.
22. De Langhe S, Haataja L, Senadheera D, Groffen J, Heisterkamp N,. Interaction of the small GTPase Rac3 with NRBP, a protein with a kinase-homology domain. Int J Mol Med 2002; 9 (5): 451-459.
23. Mahrour N, Redwine WB, Florens L, Swanson SK, Martin-Brown S, Bradford WD, Staehling-Hampton K, Washburn MP, Conaway RC, Conaway JW,. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 2008; 283 (12): 8005-8013.
24. Chua JJ, Ng MM, Chow VT,. The non-structural 3 (NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure. Virus Res 2004; 102 (2): 151-163.